Medications and Drugs
Brand Names: Ogen 0.625, Ogen 1.25, Ogen 2.5
Generic Name: estropipate (Pronunciation: ES troe PIP ate)
What is estropipate (Ogen 0.625, Ogen 1.25, Ogen 2.5)?
Estropipate is a form of estrogen. Estrogen is a female sex hormone necessary for many processes in the body.
Estropipate may also be used for purposes other than those listed in this medication guide.
Estropipate 0.75 mg-BAR
round, yellow, imprinted with barr, 555 727
Estropipate 0.75 mg-MYL
round, yellow, imprinted with M E7
Estropipate 0.75 mg-WAT
round, yellow, imprinted with WATSON 414
Estropipate 1.5 mg-BAR
round, peach, imprinted with barr, 555 728
Estropipate 1.5 mg-MYL
round, peach, imprinted with M E8
Estropipate 1.5 mg-WAT
round, orange, imprinted with WATSON, 415
Estropipate 3 mg-BAR
round, blue, imprinted with barr, 555 729
Estropipate 3 mg-WAT
round, blue, imprinted with WATSON 416
Ogen 0.625 mg-PFI
oval, yellow, imprinted with U 3772
Ogen 1.25 mg-PFI
oval, orange, imprinted with U 1773
Ogen 2.5 mg-PFI
oval, blue, imprinted with U 3774
Ortho-Est 0.75 mg
diamond, white, imprinted with ORTHO 1801
Ortho-Est 1.5 mg
diamond, lavender, imprinted with ORTHO 1800
What are the possible side effects of estropipate (Ogen 0.625, Ogen 1.25, Ogen 2.5)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:
Other less serious side effects are more likely to occur, such as:
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about estropipate (Ogen 0.625, Ogen 1.25, Ogen 2.5)?
Do not use this medication if you have any of the following conditions: a history of stroke or blood clot, circulation problems, a hormone-related cancer such as breast or uterine cancer, or abnormal vaginal bleeding.
Estropipate increases your risk of developing endometrial hyperplasia, a condition that may lead to cancer of the uterus. Taking progestins while using estropipate may lower this risk. If your uterus has not been removed, your doctor may prescribe a progestin for you to take while you are using estropipate.
Long-term estropipate treatment may increase your risk of breast cancer, heart attack, or stroke. Talk with your doctor about your individual risks before using estropipate long-term. Your doctor should check your progress on a regular basis (every 3 to 6 months) to determine whether you should continue this treatment.
Have regular physical exams and self-examine your breasts for lumps on a monthly basis while using estropipate.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?